Open Access · CC BY 4.0
Expression of concern "hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma"
EXCLI Journal · 02.11.2026 · 25 · 1634-1635
DOI: 10.17179/excli2026-9895 ↗Kurz gefasst
Fachartikel in der Zeitschrift EXCLI Journal, online erschienen am 02.11.2026. Verfasst von Mahdi Abdoli Shadbad und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shadbad, M. A., Baghbanzadeh, A., & Baradaran, B. (2026). Expression of concern "hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma". EXCLI Journal, 25, 1634-1635. https://doi.org/10.17179/excli2026-9895
Vancouver
Shadbad MA, Baghbanzadeh A, Baradaran B. Expression of concern "hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma". EXCLI Journal. 2026;25:1634-1635. doi:10.17179/excli2026-9895
BibTeX
@article{Shadbad2026,
author = {Shadbad, Mahdi Abdoli and Baghbanzadeh, Amir and Baradaran, Behzad},
title = {Expression of concern "hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma"},
journal = {EXCLI Journal},
year = {2026},
volume = {25},
pages = {1634--1635},
doi = {10.17179/excli2026-9895}
}
EUVIMED